Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions

BACKGROUND: This study was to investigate the efficacy and safety of anlotinib for elderly patients with previously treated extensive-stage small cell lung cancer (ES-SCLC) and the prognostic significance of common adverse reactions. PATIENTS AND METHODS: A total of 79 elderly patients (≥60 years) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Peng-Fei, Xu, Ning, Li, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646458/
https://www.ncbi.nlm.nih.gov/pubmed/33173346
http://dx.doi.org/10.2147/CMAR.S275624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646458/
https://www.ncbi.nlm.nih.gov/pubmed/33173346
http://dx.doi.org/10.2147/CMAR.S275624

Ejemplares similares